Developing antisense oligomer biotics "asobiotics" as precision antibacterials: designs, strategies, and considerations for future success. [PDF]
Moustafa DA +9 more
europepmc +1 more source
Important Aspects of siRNA Design for Optimal Efficacy In Vitro and In Vivo. [PDF]
Bhakta-Yadav MS, Brown TL.
europepmc +1 more source
Silencing HPV: the rise of RNA therapeutics in cervical cancer. [PDF]
Khorramabadi SM +4 more
europepmc +1 more source
Protein production is an early biomarker for RNA‐targeted therapies [PDF]
Alex, Jacob +10 more
core +2 more sources
Advances in peptide nucleic acid for targeting RNA and genomic DNA. [PDF]
De A +6 more
europepmc +1 more source
Intracellular cholesterol transporters and modulation of hepatic lipid metabolism: implications for diabetic dyslipidaemia and steatosis [PDF]
Caridis, Anna-Maria +3 more
core +1 more source
From Genomic Diagnosis to Personalized RNA Medicine: Advances in Next-Generation Sequencing and N-of-1 Antisense Oligonucleotide Therapies for Rare Genetic Diseases. [PDF]
Rodriguez Carstens P +2 more
europepmc +1 more source
Nanotech meets antibiotics: nucleotide antibiotics delivered by lipid nanoparticles. [PDF]
Kim B, Kim D, Ryu CM.
europepmc +1 more source
Harnessing CRISPR-dCas13Rx to identify novel antisense targets for therapeutic splicing modulation. [PDF]
Singh RN, Alves CRR.
europepmc +1 more source

